Found: 117
Select item for more details and to access through your institution.
Regulation of thiamine and pyruvate decarboxylase genes by Pdc2 in Nakaseomyces glabratus (Candida glabrata) is complex.
- Published in:
- G3: Genes | Genomes | Genetics, 2024, v. 14, n. 8, p. 1, doi. 10.1093/g3journal/jkae132
- By:
- Publication type:
- Article
Use of plasma P‐tau217 for enrichment in the Phase 2 PROSPECT‐ALZ study of LY3372689 in early symptomatic Alzheimer's disease: Cohort selection and baseline characteristics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.074725
- By:
- Publication type:
- Article
Explicitly Resolved Cloud Feedbacks in the Radiative‐Convective Equilibrium Model Intercomparison Project.
- Published in:
- Journal of Advances in Modeling Earth Systems, 2023, v. 15, n. 11, p. 1, doi. 10.1029/2023MS003738
- By:
- Publication type:
- Article
Circulating and Cardiac Tissue miRNAs in Children with Dilated Cardiomyopathy.
- Published in:
- Journal of Cardiovascular Development & Disease (JCDD), 2023, v. 10, n. 9, p. 391, doi. 10.3390/jcdd10090391
- By:
- Publication type:
- Article
Pyruvate decarboxylase and thiamine biosynthetic genes are regulated differently by Pdc2 in S. cerevisiae and C. glabrata.
- Published in:
- PLoS ONE, 2023, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0286744
- By:
- Publication type:
- Article
Linoleate-Enrichment of Mitochondrial Cardiolipin Molecular Species Is Developmentally Regulated and a Determinant of Metabolic Phenotype.
- Published in:
- Biology (2079-7737), 2023, v. 12, n. 1, p. 32, doi. 10.3390/biology12010032
- By:
- Publication type:
- Article
Properties, Changes, and Controls of Deep-Convecting Clouds in Radiative-Convective Equilibrium.
- Published in:
- Journal of Advances in Modeling Earth Systems, 2022, v. 14, n. 6, p. 1, doi. 10.1029/2021MS002917
- By:
- Publication type:
- Article
Walking and resting blood pressure: An inter-individual response difference meta-analysis of randomized controlled trials.
- Published in:
- Science Progress, 2022, v. 105, n. 2, p. 1, doi. 10.1177/00368504221088375
- By:
- Publication type:
- Article
An elderly man with bilateral cavitary lesions in the globus pallidus.
- Published in:
- Brain Pathology, 2022, v. 32, n. 2, p. 1, doi. 10.1111/bpa.13025
- By:
- Publication type:
- Article
Oxidative Stress and Inflammation Are Associated With Age-Related Endothelial Dysfunction in Men With Low Testosterone.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 2, p. e500, doi. 10.1210/clinem/dgab715
- By:
- Publication type:
- Article
Patient Perspectives and Experiences of Preventive Treatments and Self-Injectable Devices for Migraine: A Focus Group Study.
- Published in:
- Patient, 2022, v. 15, n. 1, p. 93, doi. 10.1007/s40271-021-00525-z
- By:
- Publication type:
- Article
Circulating cyclic adenosine monophosphate concentrations in milrinone treated paediatric patients after congenital heart surgery.
- Published in:
- Cardiology in the Young, 2021, v. 31, n. 9, p. 1393, doi. 10.1017/S1047951121000251
- By:
- Publication type:
- Article
Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Benefit-Risk Assessment of Galcanezumab Versus Placebo for the Treatment of Episodic and Chronic Migraine Using the Metrics of Number Needed to Treat and Number Needed to Harm.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Shift from high-frequency to low-frequency episodic migraine in patients treated with Galcanezumab: results from two global randomized clinical trials.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01222-w
- By:
- Publication type:
- Article
Efficacy and safety of galcanezumab for preventive treatment of migraine: a systematic review and meta-analysis.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine.
- Published in:
- Cephalalgia, 2021, v. 41, n. 3, p. 340, doi. 10.1177/0333102420966658
- By:
- Publication type:
- Article
Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01215-9
- By:
- Publication type:
- Article
Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study.
- Published in:
- Quality of Life Research, 2021, v. 30, n. 2, p. 455, doi. 10.1007/s11136-020-02632-0
- By:
- Publication type:
- Article
Correction to: Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Clouds and Convective Self‐Aggregation in a Multimodel Ensemble of Radiative‐Convective Equilibrium Simulations.
- Published in:
- Journal of Advances in Modeling Earth Systems, 2020, v. 12, n. 9, p. 1, doi. 10.1029/2020MS002138
- By:
- Publication type:
- Article
Circulating endothelial cell derived microvesicles are elevated with hypertension and associated with endothelial dysfunction.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2020, v. 98, n. 8, p. 557, doi. 10.1139/cjpp-2020-0044
- By:
- Publication type:
- Article
Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials.
- Published in:
- Journal of Headache & Pain, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s10194-020-01148-9
- By:
- Publication type:
- Article
Evaluation of injection-site-related adverse events with galcanezumab: a post hoc analysis of phase 3 studies in participants with migraine.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Response to 'Do different treatment strategies of galcanezumab have similar effect on migraine?'.
- Published in:
- European Journal of Neurology, 2020, v. 27, n. 5, p. e25, doi. 10.1111/ene.14168
- By:
- Publication type:
- Article
Efficacy of galcanezumab in patients with episodic migraine and a history of preventive treatment failure: results from two global randomized clinical trials.
- Published in:
- European Journal of Neurology, 2020, v. 27, n. 4, p. 609, doi. 10.1111/ene.14114
- By:
- Publication type:
- Article
Impact of a Pharmacy-Driven Transitions of Care Medication Reconciliation Following Hospitalization.
- Published in:
- Journal of Pharmacy Technology, 2020, v. 36, n. 2, p. 68, doi. 10.1177/8755122519900507
- By:
- Publication type:
- Article
Correction to: Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correction to: Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2).
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
The Impact of Timing of Exercise Initiation on Weight Loss: An 18-Month Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Correction to: Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2).
- Published in:
- Journal of Headache & Pain, 2019, v. 20, n. 1, p. 1, doi. 10.1186/s10194-019-1024-x
- By:
- Publication type:
- Article
Insufficient sleep is associated with a pro‐atherogenic circulating microRNA signature.
- Published in:
- Experimental Physiology, 2019, v. 104, n. 6, p. 975, doi. 10.1113/EP087469
- By:
- Publication type:
- Article
Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials.
- Published in:
- Headache: The Journal of Head & Face Pain, 2019, v. 59, n. 6, p. 834, doi. 10.1111/head.13508
- By:
- Publication type:
- Article
Circulating Microparticles Are Elevated in Treated HIV -1 Infection and Are Deleterious to Endothelial Cell Function.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Physician characteristics associated with treatment initiation patterns in idiopathic pulmonary fibrosis.
- Published in:
- Chronic Respiratory Disease, 2019, v. 16, n. 1, p. 1, doi. 10.1177/1479973119879678
- By:
- Publication type:
- Article
Preventive effects of galcanezumab in adult patients with episodic or chronic migraine are persistent: data from the phase 3, randomized, double-blind, placebo-controlled EVOLVE-1, EVOLVE-2, and REGAIN studies.
- Published in:
- Journal of Headache & Pain, 2018, v. 19, n. 1, p. 1, doi. 10.1186/s10194-018-0951-2
- By:
- Publication type:
- Article
A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine.
- Published in:
- Patient Preference & Adherence, 2018, v. 12, p. 2413, doi. 10.2147/PPA.S182563
- By:
- Publication type:
- Article
Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2018, v. 75, n. 9, p. 1080, doi. 10.1001/jamaneurol.2018.1212
- By:
- Publication type:
- Article
Comparison between prefilled syringe and autoinjector devices on patient-reported experiences and pharmacokinetics in galcanezumab studies.
- Published in:
- Patient Preference & Adherence, 2018, v. 12, p. 1785, doi. 10.2147/PPA.S170636
- By:
- Publication type:
- Article
An Open-Label, Phase II Study of the Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (PIPF-002).
- Published in:
- Pulmonary Therapy, 2018, v. 4, n. 1, p. 59, doi. 10.1007/s41030-018-0053-y
- By:
- Publication type:
- Article
Real-World Practice Patterns for Prevention and Management of Potential Adverse Events with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.
- Published in:
- Pulmonary Therapy, 2018, v. 4, n. 1, p. 103, doi. 10.1007/s41030-018-0056-8
- By:
- Publication type:
- Article
Nebivolol, But Not Metoprolol, Treatment Improves Endothelial Fibrinolytic Capacity in Adults With Elevated Blood Pressure.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Regular aerobic exercise reduces endothelin-1-mediated vasoconstrictor tone in overweight and obese adults.
- Published in:
- Experimental Physiology, 2017, v. 102, n. 9, p. 1133, doi. 10.1113/EP086454
- By:
- Publication type:
- Article